About Our Lab

Health Diagnostic Laboratory, Inc. (HDL, Inc.) is an accredited clinical laboratory focused on disease state management with supporting clinical laboratory testing targeting patients with cardiovascular disease (CVD), heart failure, stroke, diabetes mellitus (DM), metabolic syndrome (MS), and nonalcoholic steatohepatitis or fatty liver disease (NASH). HDL, Inc. offers a unique menu of clinical laboratory test results, selected based on their ability to discern the information required to understand each patient’s disease state.

We are not just another traditional clinical laboratory. HDL, Inc. is founded on the idea that in order to impact the alarming increases in chronic disease, it is necessary to approach the disease and treatment with an understanding that involves our company, physicians and their patients. We diligently work with physicians and patients to understand the disease, provide answers, education and support to identify and reverse health risks.

Our testing options allow physicians to understand their patients’ disease on a personal level. Our disease state options support the individual achievement of health.

Scientific Excellence

The convergence of different scientific and technical disciplines is creating a new wave of biomedical knowledge and Health Diagnostic Laboratory is at the forefront of this. Health Diagnostic Laboratory maintains a consistent thread of scientific excellence through all its operations resulting in quality laboratory testing, as well as, excellence in health state management partnerships with the physicians and patients served by our services.

Our service program is designed to help patients better understand and manage their disease through prevention, education, lifestyle changes, coordination of healthcare services and adherence to prescribed plans of care (POC's) through internet-based tools. The program is designed to monitor clinical health outcome measures and track changes in expenditures and patient compliance.

HDL, Inc. is founded on the idea that all people and their diseases are not created equally. In order to reverse the alarming increase in chronic diseases, it will require that we examine emerging biomarkers that are more indicative of the mechanics of affected systems. At HDL, Inc., we take a comprehensive systems biology approach and are dedicated to providing answers needed to delay, reverse or prevent cardiac disease, metabolic syndrome, diabetes and/or fatty liver disease. This approach empowers physicians and patients, resulting in better clinical outcomes and quality of life improvement.